Literature DB >> 23410519

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.

Angela Y Jia1, Mireia Castillo-Martin, Josep Domingo-Domenech, Dennis M Bonal, Marta Sánchez-Carbayo, Jose M Silva, Carlos Cordon-Cardo.   

Abstract

miRNAs are small noncoding RNAs with critical roles in a large variety of biological processes such as development and tumorigenesis. miRNA expression profiling has been reported to be a powerful tool to classify tissue samples, including cancers, based on their developmental lineage. In this study, we have profiled the expression of miRNAs in bladder carcinoma in situ (CIS) and distinct cell compartments of the normal bladder, namely umbrella and basal-intermediate urothelial cells, as well as the muscularis propria. We identified several miRNAs differentially expressed between umbrella and basal-intermediate cells (miR-133a, miR-139-3p, miR-142-3p, miR-199b-5p, and miR-221). In situ hybridization confirmed the expression of miR-133a and miR-139-3p in umbrella cells, and miR-142-3p in basal-intermediate cells. Strikingly, miRNA expression levels of CIS most closely resembled the miRNA profile of umbrella cells. Finally, we examined well-established umbrella and basal-intermediate cell immunohistochemical biomarkers in an independent series of CIS samples. Again, this analysis revealed the significant expression of umbrella-specific markers in CIS when compared to non-CIS lesions. Overall, our studies represent a comprehensive and accurate description of the different miRNAs expressed in CIS tumors and three distinct histological areas of the urinary bladder. Notably, this study provides evidence of the possible origin relationship between CIS and normal umbrella cells.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410519      PMCID: PMC3620415          DOI: 10.1016/j.ajpath.2013.01.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Authors:  Patricia Puerta-Gil; Rodrigo García-Baquero; Angela Y Jia; Sara Ocaña; Miguel Alvarez-Múgica; Jose L Alvarez-Ossorio; Carlos Cordon-Cardo; Fernando Cava; Marta Sánchez-Carbayo
Journal:  Am J Pathol       Date:  2012-03-15       Impact factor: 4.307

Review 3.  Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.

Authors:  David J McConkey; Sangkyou Lee; Woonyoung Choi; Mai Tran; Tadeusz Majewski; Sooyong Lee; Arlene Siefker-Radtke; Colin Dinney; Bogdan Czerniak
Journal:  Urol Oncol       Date:  2010 Jul-Aug       Impact factor: 3.498

4.  Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.

Authors:  J K McKenney; J A Gomez; S Desai; M W Lee; M B Amin
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

5.  Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.

Authors:  Z T Zhang; J Pak; H Y Huang; E Shapiro; T T Sun; A Pellicer; X R Wu
Journal:  Oncogene       Date:  2001-04-12       Impact factor: 9.867

Review 6.  Lessons from common markers of tumor-initiating cells in solid cancers.

Authors:  Olivier Gires
Journal:  Cell Mol Life Sci       Date:  2011-07-24       Impact factor: 9.261

7.  p63 expression profiles in human normal and tumor tissues.

Authors:  Charles J Di Como; Marshall J Urist; Irina Babayan; Marija Drobnjak; Cyrus V Hedvat; Julie Teruya-Feldstein; Kamal Pohar; Axel Hoos; Carlos Cordon-Cardo
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

8.  Genetic variants in miRNAs predict bladder cancer risk and recurrence.

Authors:  Meilin Wang; Haiyan Chu; Pu Li; Lin Yuan; Guangbo Fu; Lan Ma; Danni Shi; Dongyan Zhong; Na Tong; Chao Qin; Changjun Yin; Zhengdong Zhang
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

9.  A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

Authors:  Merle Hanke; Kai Hoefig; Hartmut Merz; Alfred C Feller; Ingo Kausch; Dieter Jocham; Jens M Warnecke; Georg Sczakiel
Journal:  Urol Oncol       Date:  2009-04-17       Impact factor: 3.498

10.  miRBase: integrating microRNA annotation and deep-sequencing data.

Authors:  Ana Kozomara; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

View more
  12 in total

1.  Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.

Authors:  Ramesh Padmanabhan; Isabel R Hendry; Jennifer R Knapp; Bin Shuai; William J Hendry
Journal:  Cell Biol Toxicol       Date:  2017-03-06       Impact factor: 6.691

Review 2.  MiR-139-5p: promising biomarker for cancer.

Authors:  He-da Zhang; Lin-hong Jiang; Da-wei Sun; Jian Li; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-02-19

Review 3.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 4.  Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?

Authors:  Maria Schubert; Kerstin Junker; Joana Heinzelmann
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-12       Impact factor: 4.553

5.  Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse.

Authors:  Mick D Edmonds; Christine M Eischen
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

6.  Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells.

Authors:  Qian Liu; Hui Liu; Hepeng Cheng; Yang Li; Xiaodong Li; Chaoyang Zhu
Journal:  Onco Targets Ther       Date:  2017-05-05       Impact factor: 4.147

7.  Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.

Authors:  Lui Ng; Timothy Ming-Hun Wan; Johnny Hon-Wai Man; Ariel Ka-Man Chow; Deepak Iyer; Guanghua Chen; Thomas Chung-Cheung Yau; Oswens Siu-Hung Lo; Dominic Chi-Chung Foo; Jensen Tung-Chung Poon; Wai-Keung Leung; Roberta Wen-Chi Pang; Wai-Lun Law
Journal:  Oncotarget       Date:  2017-04-18

8.  EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma.

Authors:  Yingqin Li; Qingmei He; Xin Wen; Xiaohong Hong; Xiaojing Yang; Xinran Tang; Panpan Zhang; Yuan Lei; Ying Sun; Jian Zhang; Yaqin Wang; Jun Ma; Na Liu
Journal:  Cell Death Differ       Date:  2018-10-23       Impact factor: 15.828

9.  MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

Authors:  A Y Jia; M Castillo-Martin; D M Bonal; M Sánchez-Carbayo; J M Silva; C Cordon-Cardo
Journal:  Br J Cancer       Date:  2014-05-13       Impact factor: 7.640

10.  Plasma Exosome-derived MicroRNAs as Novel Biomarkers of Traumatic Brain Injury in Rats.

Authors:  Pengcheng Wang; Haoli Ma; Yuxian Zhang; Rong Zeng; Jiangtao Yu; Ruining Liu; Xiaoqing Jin; Yan Zhao
Journal:  Int J Med Sci       Date:  2020-02-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.